AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30, 2019.

AMETEK's second quarter 2019 sales were a record $1.29 billion, up 7% over the second quarter of 2018, with organic sales growth of 3%. Operating income increased 9% to a record $295.4 million and operating margins were 22.9% in the quarter, up 60 basis points over the prior-year period.

On a GAAP basis, second quarter earnings per diluted share were $0.94. Adjusted earnings, which adds back non-cash, after-tax, acquisition-related intangible amortization, were $1.05 per diluted share, a 14% increase over the prior year's comparable period. A reconciliation of reported GAAP earnings to adjusted earnings is included in the financial tables accompanying this release and on the AMETEK website.

"I am very pleased with our strong performance in the second quarter," said David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Continued solid organic sales growth, combined with contributions from recent acquisitions and excellent operating performance helped drive 14% earnings growth in the quarter. Given the strength of these results and our outlook for the remainder of 2019, we are again raising our earnings guidance for the full year."

Electronic Instruments Group (EIG)

EIG sales in the second quarter were $820.2 million, up 10% over the second quarter of 2018. Operating income for the quarter increased 10% to $212.9 million, and operating income margins were 26.0%.

"EIG had an outstanding quarter with strong sales growth and excellent operating performance," noted Mr. Zapico. "Sales growth was driven by solid organic sales growth and contributions from the recent acquisitions of Motec, Forza, Telular and Spectro Scientific. The higher sales combined with our operational excellence initiatives delivered impressive core margin expansion in the quarter."

Electromechanical Group (EMG)Sales for EMG in the second quarter were $469.2 million, up 1% over the same quarter in 2018. EMG operating income for the quarter was a record $101.1 million, an increase of 7% over last year's second quarter. Operating income margins were 21.5%, up 120 basis points over the prior year period.

"EMG also delivered an outstanding second quarter with solid organic sales growth and exceptional operating performance," commented Mr. Zapico. "Operating margins increased sharply as our EMG businesses continue to deliver on our Operational Excellence initiatives."

2019 Outlook"AMETEK's performance through the first half of the year has firmly positioned us for strong sales and earnings growth in 2019. Our success speaks to the strength of the AMETEK Growth Model and our leading positions in attractive, niche market segments," noted Mr. Zapico.

"For all of 2019, we continue to expect overall sales to be up high single digits on a percentage basis compared to 2018, driven by contributions from recent acquisitions and 3% to 5% organic sales growth. We now expect adjusted earnings per diluted share to be in the range of $4.04 to $4.10, an increase of 10% to 12% over the prior year's comparable basis. This is an increase from our previous adjusted guidance range of $3.98 to $4.08 per diluted share," he added.

"Overall sales in the third quarter are expected to be up high single digits on a percentage basis compared to the third quarter of 2018. Adjusted earnings per diluted share are expected to be in the range of $1.00 to $1.02, an increase of 10% to 12% on a comparable basis over last year's third quarter," concluded Mr. Zapico.

Corporate Profile

AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of approximately $5.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.